For clinical trial participants and healthcare professionals: always follow the storage instructions on the IMP label and those provided by the trial site pharmacist
The American Diabetes Association Standards of Care and American Association of Clinical Endocrinology guidelines for obesity management acknowledge that patients with depression or anxiety can be candidates for pharmacological weight loss interventions, provided their mental health condition is adequately controlled
Huang et al., Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro, Drug Des
Many states have authorized NPs to provide primary care services directly and often without physician oversight
Many telehealth GLP-1 platforms operate on a cash-pay-only basis, but Midis insurance integration can dramatically reduce out-of-pocket costs for eligible patients
There is no medical advantage to reaching 2.4 mg if your weight loss goals are met at 1.7 mg or 2.0 mg, making individualized dosing both safer and more practical